Please login to the form below

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.


Inflammatory bowel disease (IBD) affects more than 250,000 patients in the UK. Treatment strategies have progressed to treating beyond the symptoms of IBD, aiming to reduce mucosal inflammation, sustain remission and prevent bowel damage. 

Steroids have a place in the treatment pathway but do not sustain remission and are associated with significant side effects.The European Crohn’s and Colitis Organisation (ECCO) defines appropriate steroid use and recommends an exit strategy for steroid-dependent patients. However, gastroenterologists are not aware that inappropriate steroid use occurs in their own clinical practice.

Using a simple digital tool, UK experts audited their own practice and were surprised to see high steroid use among their patients. The expert group became advocates for change, motivated to share their data, targeting more than 300 UK HCPs with high steroid use, which comprises approximately 22% of UK IBD clinicians. Awareness of inappropriate steroid use, and the changes driven by the self-realisation of the need to optimise steroids, have the potential to impact the care delivered to over 50,000 UK IBD patients.

13th July 2016



Company Details

Lucid Group Communications Limited

+44 01494 755712

Contact Website

Burleighfield House
London Road
HP10 9RF

Latest content on this profile

Fulfilling Dreams, Talent and Ambition – The Lucid Futures Academy
The inaugural class of 2018 graduate from Lucid’s Futures Academy
Lucid Group Communications Limited
Getting in the LUCID SPIRIT!
Lucid Group launches charity partnership with Wycombe Homeless Connection
Lucid Group Communications Limited
The Lucid Festival of Magic
Lucid Group threw a spellbinding event to celebrate eleven years of transforming lives with their standout new branding taking centre stage.
Lucid Group Communications Limited
Lighthouse Medical Communications US bolster their senior scientific team

Lucid Group Communications Limited
Vivid Medical Communications Supports the 10th Anniversary of Rare Diseases Day 2018
Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.
Lucid Group Communications Limited
The Lucid Festival of Magic - A Spellbinding Event for All
The Lucid ‘Festival of Magic’ was a celebration of their pioneering work and the people that made it possible.
Lucid Group Communications Limited